Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"
- PMID: 31802401
- PMCID: PMC7007435
- DOI: 10.1007/s40262-019-00848-z
Authors' Reply to Krebs-Brown et al. Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?"
Conflict of interest statement
D Concordet, P. Gandia, J.L. Montastruc, A. Bousquet-Mélou, P. Lees, A.A. Ferran and Pierre-Louis Toutain have no conflicts of interest that are directly relevant to the content of this reply.
Comment on
-
Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?Clin Pharmacokinet. 2020 Jan;59(1):1-5. doi: 10.1007/s40262-019-00812-x. Clin Pharmacokinet. 2020. PMID: 31432471 Free PMC article.
-
Comment on: "Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?".Clin Pharmacokinet. 2020 Feb;59(2):265-267. doi: 10.1007/s40262-019-00847-0. Clin Pharmacokinet. 2020. PMID: 31802400 Free PMC article. No abstract available.
References
-
- Anonymous. Status of EMEA scientific guidelines and European pharmacopoeia monographs and chapters in the regulatory framework applicable to medicinal products. 2008. https://www.ema.europa.eu/en/documents/scientific-guideline/status-emea-.... Accessed 21 Nov 2019.
-
- Anonymous. Concept paper on the development of product-specific guidance on demonstration of bioequivalence. 2013. https://www.ema.europa.eu/en/documents/scientific-guideline/concept-pape.... Accessed 21 Nov 2019.
-
- Anonymous. An open-label, single-dose, randomized, two-period, two-sequence crossover, single-center trial to assess bioequivalence of 600 µg Ievothyroxine new formulation versus old formulation administered orally as 3 white tablets of 200 µg in healthy volunteers. 2014. https://ansm.sante.fr/var/ansm_site/storage/original/application/3606e51.... Accessed 21 Nov 2019.
-
- Anonymous. Draft guidance on levothyroxine sodium (p. 2). 2018. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformat.... Accessed 4 Oct 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources